Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)

INTRODUCTION AND OBJECTIVES: Liver function tests (LFT) abnormalities are reported in up to 50% of COVID-19 patients, and metabolic comorbidities are associated with poorer outcomes. The aim of the study was to determine the prevalence of liver steatosis and fibrosis in patients with COVID-19 and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Mendez, Ivan, Aquino-Matus, Jorge, Gall, Sofia Murua-Beltrán, Prieto-Nava, Jose D., Juarez-Hernandez, Eva, Uribe, Misael, Castro-Narro, Graciela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577265/
https://www.ncbi.nlm.nih.gov/pubmed/33099028
http://dx.doi.org/10.1016/j.aohep.2020.09.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577265/
https://www.ncbi.nlm.nih.gov/pubmed/33099028
http://dx.doi.org/10.1016/j.aohep.2020.09.015

Ejemplares similares